Keisuke Goto

26PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersSolid tumoursCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Nov 06, 2026
KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma.

|Aug 08, 2026
Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy.

|Aug 06, 2026
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Sep 15, 2025
TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma.

Naofumi Nomura, Yohei Sekino, Tetsutaro Hayashi

|Sep 15, 2025
Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.

Kohei Kobatake, Keisuke Goto, Tomoya Hatayama

Pageof 5

Frequent Collaborators

18 joint publications

Nobuyuki Hinata

16 joint publications

Kohei Kobatake

13 joint publications

Yohei Sekino

6 joint publications

Shunsuke Miyamoto